Nobuya Ikeda
Corporate Officer, Head of R&D Planning & Management Function, R&D Division
Kenji Shigeta
Corporate Officer, Head of Global Oncology Marketing, Oncology Business Unit
Paul Diolosa
Head of American Regent Unit
Mitsuhiro Matsumoto
Outside Audit & Supervisory Board Member (Independent Auditor)
Shizuko Ueno
Director, Executive Officer, Head of Japan Business Unit and Head of Medical Affairs Division, Japan Business Unit
Naoki Shimizu
Head of Global QA, Chief Quality Officer (CQO)
Yo Honma
Outside Director (Independent Director), Chairperson of the Compensation Committee
Yukiko Imazu
Outside Audit & Supervisory Board Member (Independent Auditor)
Kentaro Asakura
Corporate Officer, Head of Corporate Communications Department, Global Corporate Planning & Management
Koichi Nonaka
Corporate Officer, Head of Technology Development Supervisory Department, Technology Division
Reiko Kinoshita
Outside Director (Independent Director)
Kento Wada
Head of Clinical Safety & Pharmacovigilance Unit
Junichi Ashihara
Corporate Officer, Head of Japan Plant Management Supervisory Department, Technology Division
Hiroto Kashiwase
Head of Technology Unit
Tetsuya Iwabuchi
Corporate Officer, In charge of Business Development
Takaaki Nishii
Outside Director (Independent Director), Chairperson of the Board
Manabu Murata
Head of Global Internal Audit
James Felix
Head of Global DX, Chief Digital Transformation Officer (CDXO)
Hanako Saito
Corporate Officer, In charge of QA and CSPV
Takashi Matsumoto
Director, Senior Executive Officer, Head of Global HR, CHRO
Oliver Appelhans
Head of EU Specialty Business Unit
Tetsuya Ohira
Corporate Officer, Head of Corporate Planning Department, Global Corporate Planning & Management
Stuart Mackey
Head of Global Business Development
Hiroshi Masumoto
Executive Officer, Head of Data Intelligence Department, Global DX
Koji Ogawa
Head of Global Corporate Planning & Management, Chief Financial Officer (CFO)
Atsushi Tsukamoto
Corporate Officer, Head of Corporate Strategy & Business Portfolio Department, Global Corporate Strategy
Naoto Tsukaguchi
Head of Global Legal & IP, General Counsel (GC)
Hiroya Senda
Corporate Officer, Head of Sales & Marketing Division, Japan Business Unit
Akihiro Tokumoto
Corporate Officer, Head of Human Resources Department, Global HR
Koji Sato
Corporate Officer, Head of Technology Division and Head of Technology Planning Supervisory Department, Technology Division
Chikara Yoshida
Head of Global Government Affairs
Yasuhiro Komatsu
Outside Director (Independent Director)
Tomohiro Kodama
Corporate Officer, Head of Finance & Accounting Department, Global Corporate Planning & Management
Hideaki Noji
Corporate Officer, Head of Business Management Department, Japan Business Unit
Ken Takeshita
Head of Research & Development Unit
Hiroyuki Okuzawa
Representative Director, President & CEO
Yuki Abe
Corporate Officer, Head of R&D division and Head of Research Function, R&D Division
Terumichi Yokoyama
Audit & Supervisory Board Member
Sunao Manabe
Representative Director, Executive Chairperson
Masako Watanabe
Outside Audit & Supervisory Board Member (Independent Auditor)
Nobuo Murakami
Head of Global Corporate Strategy, Chief Strategy Officer (CStO)
Takahiro Uchida
Head of Daiichi Sankyo Healthcare Unit
Miyuki Arai
Audit & Supervisory Board Member
Joseph Kenneth Keller
Director, Head of Oncology Business Unit
Chiaki Matsumoto
Corporate Officer, Head of Regulatory Affairs Strategy Department, Development Function, R&D Division
Toshi Kajiro
Corporate Officer, Head of Compliance Strategy and Excellence, Global Compliance & Risk Management
Satoru Ogawa
Corporate Officer, Head of Secretariat Department
Akio Sakurai
Corporate Officer, Special Assignment on Japan Business
Kiminori Nagao
Head of ASCA Business Unit
Akihiro Watanabe
Outside Director (Independent Director), Chairperson of the Nomination Committee
Akihiro Inoguchi
Corporate Officer, Head of Development Function, R&D Division
Matt Allegrucci
Head of Global Compliance & Risk Management, Chief Compliance Officer (CCO)